$33.34
Value $6.1B
DOCS and MU stock compared: price, dividend, valuation and results, from SEC filings.
$33.34
Value $6.1B
$778.31
Value $881B
Doximity (DOCS) has a market value of $6.1B and Micron Technology (MU) $881B. Over the last year, with dividends, DOCS moved -34.6% and MU +218.2%. The P/E is 43.7 for DOCS and 10.4 for MU. Dividend yield: DOCS none, MU 0.07%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
DOCS$6.1B
MU$881B
MU is 144 times DOCS
Revenue, 12 months
DOCS$662M
MU$133B
MU is 201 times DOCS
Net income, 12 months
DOCS$140M
MU$85.0B
MU is 608 times DOCS
Operating margin
DOCS26.3%
MU74.6%
48.3 points apart
ROIC
DOCS12.3%
MU89.7%
77.4 points apart
P/E
DOCS43.7
MU10.4
DOCS is 4.2 times MU
Dividend yield
DOCS0.0%
MU0.1%
0.1 points apart
5-year return
DOCS-54.6%
MU+931.4%
986.0 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
DOCS-54.6%
MU+931.5%
| Period | DOCSWith dividends | MUWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -34.6%Price -34.6% | +218.2%Price +217.8% |
| 3 years since November 13, 2023 | +39.6%+11.8% a yearPrice +39.6% | +951.0%+119.0% a yearPrice +940.8% |
| 5 years since November 12, 2021 | -54.6%-14.6% a yearPrice -54.6% | +931.4%+59.5% a yearPrice +906.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
DOCSDoximityMUMicron Technology
| Price | $33.34 | $778.31 |
|---|---|---|
| Market value | $6.1B | $881B |
| Enterprise value (EV) | $5.4B | $842B |
| P/E | 43.7 | 10.4 |
| P/E, 5-year median | 52.3 | 12.9 |
| P/B | 6.6 | 6.4 |
| EV/EBIT | 30.9 | 8.5 |
| Free cash flow yield | 5.0% | 6.7% |
| Revenue, 12 months | $662M | $133B |
|---|---|---|
| Net income, 12 months | $140M | $85.0B |
| Free cash flow, 12 months | $306M | $59.0B |
| Earnings per share, 12 months | $0.72 | $74.33 |
| Revenue growth, year on year | 13.1% | 256.3% |
| Revenue growth a year, past | +25.5%over 5 years | +36.9%over 5 years |
| EPS growth a year, past | +33.6%over 5 years | +70.6%over 5 years |
| Gross margin | 86.8% | 80.7% |
|---|---|---|
| Operating margin | 26.3% | 74.6% |
| Net margin | 21.1% | 63.8% |
| ROIC | 12.3% | 89.7% |
| ROE | 14.3% | 100.1% |
| Cash | $713M | $43.4B |
|---|---|---|
| Total debt | $9.1M | $5.2B |
| Net debt / EBITDA | -3.8 | -0.4 |
| Interest cover | – | 937.2× |
| Dividend yield | – | 0.1% |
|---|---|---|
| Dividend per share, 12 months | – | $0.57 |
| Dividend growth a year, past | – | – |
| Buyback yield | 7.1% | 0.1% |
| Shareholder yield | 7.1% | 0.1% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Micron Technology ($881B) is about 144.3 times Doximity ($6.1B), at today's prices.
Since November 12, 2021, DOCS's price moved -54.6% and MU's +906.9%. With dividends: DOCS -54.6% (-14.6% a year), MU +931.4% (+59.5% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Doximity and 0.07% for Micron Technology. Over the last twelve months they paid – and $0.57 per share.
At today's price, the P/E is 43.7 for DOCS and 10.4 for MU. The median of the last five years was 52.3 and 12.9, which shows where each stands against its own past.
Over the last twelve months, the net margin was 21.1% for Doximity and 63.8% for Micron Technology, and the operating margin 26.3% and 74.6%. Revenue was $662M and $133B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.